# US 2025/0145828 A1 · Transparent protein materials

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0145828 A1
- Document ID: US20250145828A1
- Status: Published application
- Kind: A1
- Application number: 18/837,709
- Filed: 2023-02-09
- Published: 2025-05-08
- Earliest claimed: 2022-02-16
- Assignees: Tandem Repeat Technologies, Inc.
- Applicants: Tandem Repeat Technologies, Inc.
- Inventors: Benjamin D. ALLEN; Huihun JUNG
- Web page: https://patentgrep.com/patent/US20250145828A1

## CPC

- C08L 89/00: Compositions of proteins; Compositions of derivatives thereof
- C07K 14/00: Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K 14/001: {by chemical synthesis}
- C07K 14/43504: {from invertebrates}
- C08J 5/18: Manufacture of films or sheets
- C08J 2389/00: Characterised by the use of proteins; Derivatives thereof
- C08L 2201/06: Biodegradable
- C08L 2201/10: Transparent films; Clear coatings; Transparent materials
- C08L 2203/12: used for fibers
- C08L 2203/16: used for films
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)

## Abstract

As can be seen, there are needs for protein materials that have desirable mechanical properties while maintaining optical transparency. The present embodiments are directed, in part, to adhesive coatings, films, and compositions comprising polypeptides such as, but not limited to, transparent adhesive coatings and films, and methods of making the same.

## Claims

### Claim 1

A polypeptide having a formula:
A1-(B1-L1-E1-P1)n-B1-G1 Formula I,
wherein
A1 is absent, is a methionine, or is an amino acid sequence 1 to 4 residues in length;
B1 is an ASTVH-rich sequence amino acid sequence 6 to 17 residues in length comprising amino acids selected from the group consisting of alanine, serine, threonine, valine, histidine, glycine, glutamine, and proline, or any combination thereof.
L1 is absent or is an amino acid sequence 1 to 7 residues in length comprising amino acids selected from the group consisting of proline, glycine, leucine, serine, and threonine, or any combination thereof;
E1 is an GLY-rich amino acid sequence 8 to 58 residues in length comprising amino acids selected from the group consisting of glycine, leucine, tyrosine, phenylalanine, and proline, or any combination thereof;
P1 is absent or is proline;
G1 is absent or is an amino acid sequence 1 to 4 residues in length;
wherein n is 4 to 100; and
(i) wherein E1 is YGFGGLYGGLFGGLGFG (SEQ ID NO:3) and B1 comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 11-88, or
(ii) wherein E1 is YGYGGLFGGLFGGLGYG (SEQ ID NO:2) and B1 comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 12, 13, 17, 19-39, 41-52, 54-59, 61, 64-68, 70-78, 80, 82-84, and 88, or
(iii) wherein E1 is YGYGGLYGGLYGGLGYG (SEQ ID NO:1) and B1 comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 12, 24, 27, 35, 37, 39, 55, 66, 67, 68, 71, 76, 82, and 83, or
(iv) wherein E1 comprises an amino acid sequence selected from the group consisting of SEQ ID NO:90-204, B1 comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 13, 21-23, 25, 26, 29, 30, 32, 34, 36, 37, 39, 44-46, 48, 50-52, 55, 57, 58, 61, 64-68, 71, 72, 74, 76-78, 80-83, and 89, and L1 is absent or is Pro.

### Claim 2 (depends on 1)

The polypeptide of claim 1, wherein the polypeptide is a synthetic or recombinant supramolecular polypeptide.

### Claim 3 (depends on 1)

The polypeptide of claim 1, wherein the A1 is methionine (M).

### Claim 4 (depends on 1)

The polypeptide of claim 1, wherein L1 is selected from the group consisting of SEQ ID NOs: 4 to 10.

### Claim 5 (depends on 1)

The polypeptide of claim 1, wherein G1 is Thr-Ser (TS) or Pro-Thr-Ser (PTS).

### Claim 6 (depends on 1)

The polypeptide of claim 1, wherein n is 4-20.

### Claim 7 (depends on 1)

The polypeptide of claim 1, wherein A1 is methionine (M), L1 is SEQ ID NO:4, and G1 is Pro-Thr-Ser (PTS).

### Claim 8 (depends on 1)

The polypeptide of claim 1, wherein E1 is YGYGGLFGGLFGGLGYG (SEQ ID NO:2) and B1 comprises is SEQ ID NO:23.

### Claim 9 (depends on 8)

The polypeptide of claim 8 comprising the amino acid sequence SEQ ID NO: 205.

### Claim 10 (depends on 1)

A composition comprising a polypeptide of claim 1 in a solvent.

### Claim 11 (depends on 10)

The composition of claim 10, wherein the polypeptide is formulated as an adhesive or film.

### Claim 12 (depends on 10)

The composition of claim 10, wherein the polypeptide is formulated as a fiber.

### Claim 13 (depends on 10)

The composition of claim 10, wherein the solvent is dimethyl sulfoxide, formic acid, 1,1,1,3,3,3-hexafluoro-2-propanol, aqueous ammonia, aqueous alkali-metal hydroxide, or aqueous urea.

### Claim 14 (depends on 10)

The composition of claim 10, wherein the solvent is an ionic liquid.

### Claim 15 (depends on 14)

The composition of claim 14, wherein the solvent is 1-ethyl-3-methylimidazolium acetate.
